Nebivolol ANOCA Treatment Randomized Trial

• Status: NOT_YET_RECRUITING
• Trial end date: 2026-09-30

Summary

To determine the effectiveness of the beta-blocker nebivolol in controlling symptoms and improving the quality of life in patients with angina and coronary microvascular dysfunction.

• Phase: PHASE3

Details

• Lead Sponsor: Spanish Society of Cardiology